Drug Information Association Logo

4th African Regulatory Conference (ARC)

Oct 22 2014 7:00AM - Oct 23 2014 6:30PM | King Fahd Palace Hotel Pointe des Almadies Dakar, B.P. 8181 Senegal

« Back to Listing

Overview 

Moving towards Regulatory Harmonisation to enhance Access to Medicines in Africa

***********************************************************************************

REGISTRATION OPEN!

Online Registration

Download the Registration Form

***********************************************************************************

 

This is the 4th African Regulatory Conference (ARC) co-organised by the Drug Information Association (DIA) and the IFPMA’s African Regulatory Network (ARN).

IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 1.3 million employees strive to develop and provide innovative medicines, biological products, and vaccines that improve patients’ lives worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

The ARN is an ad-hoc network of the Regulatory Policy and Technical Standards Committee (RPTS) of IFPMA. The association works in partnership with regulatory authorities and the pharmaceutical industry in Africa to encourage greater harmonisation of regulatory requirements with the aim to help enable faster and expanded access to good quality innovative medicines for patients.

The ARC offers the opportunity for key stakeholders active in the region including Representatives from health authorities, local and multinational pharmaceutical companies, international, governmental and non-governmental organisations to exchange progressive views on key topics of interest and identify focus areas for ongoing efforts aimed to increase patient access to new and improved medicines.

 

Simultaneous translation in French and English will be available.

To view detailed programme please click on View PDF above.

----------------------------------------------------------------------------------------------------

What the participants of the 3rd ARC are saying:

"A well placed conference which has fostered the sharing of information and best practices and openly discussion delegates regarding issues facing African Regulatory authorities and industry. Great job done."

"It’s the 3rd conference to attend. I appreciate the learning received in all ARC’s."

"The meeting is a very good platform of exchange and we have learned lessons which can help us when we are back in our country."

Featured Topics 

  • African Medicines Regulatory Harmonisation (AMRH)
  • Guidelines development and implementation
  • Common technical documentation
  • Submission requirements
  • Dossier assessment
  • End-to-end submission and approval process mapping
  • Variations management
  • Quality/Good Manufacturing Practices (GMP)/Inspections
  • Transparency/Good Regulatory Practices
  • Clinical trials capacity building

Who Should Attend 

Representatives of health authorities, regulatory affairs, quality assurance, medical, safety, research and development professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory harmonisation initiatives in Africa.

Learning Objectives 

Following the successful discussions held during the 3rd ARC in 2012 in Ghana, this edition intends to build on progress made within the region and to identify further initiatives for stakeholders to work together on the enhancement of healthcare in Africa.

This 4th ARC will provide an overview of regulatory harmonisation initiatives currently ongoing or emerging in Africa and will offer the opportunity to:

  • Provide a platform to foster collaboration between African regulatory authorities and the pharmaceutical industry
  • Share information and best practices
  • Openly discuss issues faced by African regulatory authorities and industry
  • Identify and agree on key proposals stemming from ARC discussions for further assessment and action

Strongly oriented towards informing on the current evolving regulatory landscape in Africa, and leveraging pragmatic and efficient approaches that strengthen ongoing harmonisation/convergence efforts, the conference will include panel discussions delivered during plenary and breakout sessions to maximise contributions from participants and enable deep-dived discussions of the key topics.

Special Offers 

Adjacent Events

21 October 2014

ICH endorsed Training Courses:

24 October 2014

IFPMA Workshop on Counterfeit medicines

Hotel & Travel 

Conference venue

King Fahd Palace Hotel

Pointe des Almadies

B.P. 8181, Dakar, Senegal

Tel: +221 33 869 69 69

www.kingfahdpalacehotels.com

 

 

Visa requirements

Please contact your local Senegal Embassy or Consulate for the most up-to-date information on visa requirements and how to apply for it if necessary.

For more information please visit: www.snedai.sn

 

Vaccinations

Please contact your GP for recommended vaccinations at least 4-8 weeks before travelling to Senegal.

For more information please visit: www.mdtravelhealth.com/destinations/africa/senegal.php, www.iamat.org/country_profile.cfm?id=86#profile_immunization  http://www.traveldoctor.info/vaccinations/senegal.86.html#1

Contact Information 

DIA has appointed Creative Trends to be the organising secretariat for the 4th African Regulatory Conference.

Conference Registration, Exhibitor Services, Accommodation, Transfers
Creative Trends
Osu Forico Mall, Mission Street
Near Blue Gate, Osu
P.O. Box AN 15605
Accra-North, Ghana
Tel: +233 243 288 505 or +233 200 814 184
E-mail: info@creativetrendsgh.com
or mabel@creativetrendsgh.com

Conference Programme
DIA Europe, Middle East & Africa
Kuechengasse 16
4051 Basel, Switzerland
Tel: +41 61 225 51 55
E-mail: gunta.sveke@diaeurope.org

Program Committee 

Previous Next

Agenda  

Day 1 Tuesday, Oct 21, 2014

  • 4:00PM - 7:00PM

    PRE-CONFERENCE REGISTRATION

Day 2 Wednesday, Oct 22, 2014

  • 7:30AM - 8:30AM

    REGISTRATION & WELCOME COFFEE
  • 8:30AM - 9:15AM

    Session 1: Opening

    Speaker(s):

    • Representative invited
      Ministry of Health and Prevention, Senegal
    • Jytte Lyngvig, PhD
      Senior Vice President and Managing Director
      DIA Europe, Middle East and Africa, Switzerland
    • Muriel Dona-Fologo
      GTA IRC Africa chairperson
      Sanofi, France
    • Vincent Ahonkhai, MD
      Deputy Director, Regulatory Affairs
      Bill & Melinda Gates Foundation, United States
    • Andreas Seiter
      Senior Health Specialist, Pharmaceuticals, Health, Nutrition & Population
      The World Bank, United States
  • 9:15AM - 9:45AM

    Session 2: Plenary - Current regulatory landscape in Africa - Latest developments

    Speaker(s):

    • Representative Invited
      GTA IRC Africa chairperson
      Sanofi
    • Corneille Traore
      Director
      West African Economic and Monetary Union (UEMOA) , Burkina Faso
    • Vincent Ahonkhai, MD
      Deputy Director, Regulatory Affairs
      Bill & Melinda Gates Foundation, United States
  • 9:45AM - 10:30AM

    Session 3: Plenary - Leveraging activities between regulatory agencies / bodies


    Session Chair(s):

    • Corneille Traore
      Director
      West African Economic and Monetary Union (UEMOA) , Burkina Faso

    This session will provide participants with an opportunity to get an update from regulatory agencies on the African Medicines Regulatory Harmonization (AMRH) programme. Key implementation learning amongst agencies and within the industry shall be shared.

    Speaker(s):

    • Representative Invited
      Commissioner
      Federal Commission for the Protection from Sanitary Risks
    • Samvel Azatyan, MD, PhD
      Group Lead, Capacity Building and Harmonization Support
      World Health Organization (WHO), Switzerland
    • Representative Invited
      Head of Communication and Networking, Deputy Director
      Swissmedic
    • Representative Invited
      Senior Programme Manager, Healthcare and Pharmaceuticals
      Southern African Development Community (SADC)
    • Representative Invited
      Medical Regulatory Affairs Director
      GlaxoSmithKline
    • Representative Invited
      Pharmacy Task Force coordinator
      Ministry of Health Rwanda
    • Sybil Nana Ama Ossei-Agyeman-Yeboah
      Professional Officer in Charge, Essential Medicines and Vaccines
      West African Health Organisation (WAHO), Burkina Faso
    • Representative Invited
      Deputy Registrar
      Pharmacy and Poisons Board
    • Emilienne Yissibi Pola
      Public Health Pharmacist, Consultant HPPN/OCEAC
      Organisation of the fight against endemic diseases in central Africa (OCEAC), Cameroon
  • 10:30AM - 11:00AM

    NETWORKING COFFEE BREAK IN THE EXHIBITION AREA
  • 11:00AM - 12:30PM

    Session 3: Plenary - Leveraging activities between regulatory agencies / bodies


    Session Chair(s):

    • Corneille Traore
      Director
      West African Economic and Monetary Union (UEMOA) , Burkina Faso

    This session will provide participants with an opportunity to get an update from regulatory agencies on the African Medicines Regulatory Harmonization (AMRH) programme. Key implementation learning amongst agencies and within the industry shall be shared.

    Speaker(s):

    • Representative Invited
      Commissioner
      Federal Commission for the Protection from Sanitary Risks
    • Samvel Azatyan, MD, PhD
      Group Lead, Capacity Building and Harmonization Support
      World Health Organization (WHO), Switzerland
    • Representative Invited
      Head of Communication and Networking, Deputy Director
      Swissmedic
    • Representative Invited
      Senior Programme Manager, Healthcare and Pharmaceuticals
      Southern African Development Community (SADC)
    • Representative Invited
      Medical Regulatory Affairs Director
      GlaxoSmithKline
    • Representative Invited
      Pharmacy Task Force coordinator
      Ministry of Health Rwanda
    • Sybil Nana Ama Ossei-Agyeman-Yeboah
      Professional Officer in Charge, Essential Medicines and Vaccines
      West African Health Organisation (WAHO), Burkina Faso
    • Representative Invited
      Deputy Registrar
      Pharmacy and Poisons Board
    • Emilienne Yissibi Pola
      Public Health Pharmacist, Consultant HPPN/OCEAC
      Organisation of the fight against endemic diseases in central Africa (OCEAC), Cameroon
  • 12:30PM - 2:00PM

    LUNCH BREAK - EXHIBITION AREA
  • 2:00PM - 3:30PM

    Session 4: Parallel 1 - How to Reach One Dossier for All: Good review practice and regulatory convergence in Africa


    Session Chair(s):

    • Representative Invited
      Director, Emerging Markets, Global Regulatory Affairs
      GlaxoSmithKline

    This session will be a panel discussion between regulatory agencies and the representatives of the industry. It is an opportunity to share and exchange the experiences of each counterpart (dossier preparation for the industries and dossier evaluation for the authorities)

    Speaker(s):

    • Representative Invited
      Director
      Direction de la Pharmacie et du Medicament
    • Hiiti Baran Sillo
      Director General
      Tanzania Food and Drugs Authority (TFDA), Tanzania, United Republic of
  • 2:00PM - 3:30PM

    Session 4: Parallel 2 - Improving GMP compliance in Africa; The Need to Create an Opportunity for Pragmatic Partnering between MRA and Industry

    Speaker(s):

    • Representative Invited
      Country Manager West Africa
      Pfizer Global Pharmaceuticals
  • 2:00PM - 3:30PM

    Session 4: Parallel 3 - Clinical Trial – Challenges and Opportunities in Building Capacity


    Session Chair(s):

    • Representative Invited
      Medical Director Global Access and Partnerships Program
      Janssen

    Participants will hear from regulators and industry about the status of clinical trials in Africa. The capacity building situation and its impact in multi-regional clinical trials, the role of the Regulators in reviewing the trial protocol to ensure safety for its population, the appropriateness of its scientific design, and that the protocol will be executed ethically will also be discussed

    Speaker(s):

    • Representative Invited
      Assistant Regional Director
      Research & Development new Vaccines, Immunisation and Vaccines Development Progr
    • Delese Mimi Darko
      Ag. DCE; Safety Monitoring & Clinical Trials Division
      Food and Drugs Authority, Ghana
    • Thomas Nyirenda, MD, MS
      South-South Networking and Capacity Development Manager
      European & Developing Countries Clinical Trials Partnership (EDCTP), South Africa
  • 3:30PM - 4:00PM

    NETWORKING COFFEE BREAK WITH EXHIBITORS
  • 4:00PM - 4:30PM

    Session 4: Parallel 1 - How to Reach One Dossier for All: Good review practice and regulatory convergence in Africa


    Session Chair(s):

    • Representative Invited
      Director, Emerging Markets, Global Regulatory Affairs
      GlaxoSmithKline

    This session will be a panel discussion between regulatory agencies and the representatives of the industry. It is an opportunity to share and exchange the experiences of each counterpart (dossier preparation for the industries and dossier evaluation for the authorities)

    Speaker(s):

    • Representative Invited
      Director
      Direction de la Pharmacie et du Medicament
    • Hiiti Baran Sillo
      Director General
      Tanzania Food and Drugs Authority (TFDA), Tanzania, United Republic of
  • 4:00PM - 4:30PM

    Session 4: Parallel 2 cont. - Improving GMP compliance in Africa; The Need to Create an Opportunity for Pragmatic Partnering between MRA and Industry

    Speaker(s):

    • Representative Invited
      Country Manager West Africa
      Pfizer Global Pharmaceuticals
  • 4:00PM - 4:30PM

    Session 4: Parallel 3 - Clinical Trial – Challenges and Opportunities in Building Capacity


    Session Chair(s):

    • Representative Invited
      Medical Director Global Access and Partnerships Program
      Janssen

    Participants will hear from regulators and industry about the status of clinical trials in Africa. The capacity building situation and its impact in multi-regional clinical trials, the role of the Regulators in reviewing the trial protocol to ensure safety for its population, the appropriateness of its scientific design, and that the protocol will be executed ethically will also be discussed

    Speaker(s):

    • Representative Invited
      Assistant Regional Director
      Research & Development new Vaccines, Immunisation and Vaccines Development Progr
    • Delese Mimi Darko
      Ag. DCE; Safety Monitoring & Clinical Trials Division
      Food and Drugs Authority, Ghana
    • Thomas Nyirenda, MD, MS
      South-South Networking and Capacity Development Manager
      European & Developing Countries Clinical Trials Partnership (EDCTP), South Africa
  • 4:30PM - 5:30PM

    Session 5: Plenary - Recap from parallel sessions, discussions and wrap-up
  • 5:30PM - 7:00PM

    NETWORKING RECEPTION

Day 3 Thursday, Oct 23, 2014

  • 8:30AM - 9:00AM

    Session 6: Opening - Reflexions and overview from Day One & Introduction to Day Two


    Session Chair(s):

    • Vincent Ahonkhai, MD
      Deputy Director, Regulatory Affairs
      Bill & Melinda Gates Foundation, United States
    • Corneille Traore
      Director
      West African Economic and Monetary Union (UEMOA) , Burkina Faso

    Speaker(s):

    • Fabienne Y. Benoist, PhD
      Global brand regulatory director, Tropical medicines, Malaria initiative lead
      Novartis AG, Switzerland
    • Osaretin Jaiyeola
      Director, Regulatory Affairs - Sub-Saharan Africa
      GlaxoSmithKline, Ghana
  • 9:00AM - 10:30AM

    Session 7: Plenary - Optimised dossier review process

    Speaker(s):

    • Representative Invited
      Director of Pharmacy
      Medicines and laboratories at the Ministry of Public Health
    • Representative Invited
      Director
      Direction de la Pharmacie et du Medicament
    • Representative Invited
      Pharmaceutical Coordinator
      The New Partnership For Africa's Development (NEPAD)
    • Representative Invited
      World Health Organization
  • 10:30AM - 11:00AM

    NETWORKING COFFEE BREAK IN THE EXHIBITION AREA
  • 11:00AM - 12:00PM

    Session 8: Parallel 1 - New/expedite regulatory pathways


    Session Chair(s):

    • Vincent Ahonkhai, MD
      Deputy Director, Regulatory Affairs
      Bill & Melinda Gates Foundation, United States

    This session will give an overview of new / expedite regulatory pathways for medicines and vaccines, as well as analyse lessons learned from existing pathways: what could be replicated and what should be avoided. Opportunities and recommendations will be discussed.

    Speaker(s):

    • Representative Invited
      World Health Organization
  • 11:00AM - 12:00PM

    Session 8: Parallel 2 - The complex journey of a vaccine – Questions on access from a regulatory angle

    Speaker(s):

    • Representative Invited
      Group Leader, Quality, Safety and Standards
      World Health Organisation
    • Christophe Saillez
      Senior Manager
      GSK Biologicals, Belgium
    • Representative Invited
      Deputy Registrar
      Pharmacy and Poisons Board
  • 11:00AM - 12:00PM

    Session 8: Parallel 3 - Capacity building – Training of medicines development and regulatory sciences in emerging countries

    Speaker(s):

    • Representative Invited
      Director
      Centre for Tropical Clinical Pharmacology & Therapeutics
    • Representative Invited
      Project Academic Leader
      Cooperative European Medicines Development Course (CEMDC)
    • Representative Invited
      Pharmaceutical Coordinator
      The New Partnership For Africa's Development (NEPAD)
    • Representative Invited
      Director General
      National Agency for Food & Drug Administration
  • 12:00PM - 12:30PM

    Session 9: Plenary - Recap from break-out sessions
  • 12:30PM - 2:00PM

    LUNCH BREAK - EXHIBITION AREA
  • 2:00PM - 3:30PM

    Session 10: Parallel 1 - Regulators' closed panel discussion

    Speaker(s):

    • Representative Invited
      Commissioner
      Federal Commission for the Protection from Sanitary Risks
    • Samvel Azatyan, MD, PhD
      Group Lead, Capacity Building and Harmonization Support
      World Health Organization (WHO), Switzerland
    • Representative Invited
      Head of Communication and Networking, Deputy Director
      Swissmedic
    • Representative Invited
      Chief Director, Department of Health
      Medicines Regulatory Authority
    • Representative Invited
      Senior Programme Manager, Healthcare and Pharmaceuticals
      Southern African Development Community (SADC)
    • Representative Invited
      Pharmacy Task Force coordinator
      Ministry of Health Rwanda
    • Representative Invited
      Pharmaceutical Coordinator
      The New Partnership For Africa's Development (NEPAD)
    • Sybil Nana Ama Ossei-Agyeman-Yeboah
      Professional Officer in Charge, Essential Medicines and Vaccines
      West African Health Organisation (WAHO), Burkina Faso
    • Representative Invited
      Deputy Registrar
      Pharmacy and Poisons Board
    • Corneille Traore
      Director
      West African Economic and Monetary Union (UEMOA) , Burkina Faso
    • Emilienne Yissibi Pola
      Public Health Pharmacist, Consultant HPPN/OCEAC
      Organisation of the fight against endemic diseases in central Africa (OCEAC), Cameroon
  • 2:00PM - 3:30PM

    Session 10: Parallel 2 - Industry and Stakeholders’ closed panel discussion


    Session Chair(s):

    • Representative Invited
      Global Head, Development and Regulatory Policy
      Novartis Pharmaceuticals Corporation

    This session is set-up as a panel discussion with industry representatives only. Main discussion points, comments and recommendations from this session as recorded by a rapporteur will be shared during next plenary session. Industry’s views of needs and opportunities for improvement related to the discussion points will be brought into perspective during the session.

    Speaker(s):

    • Representative Invited
      Country Manager West Africa
      Pfizer Global Pharmaceuticals
    • Representative Invited
      Medical Regulatory Affairs Director
      GlaxoSmithKline
    • Sharmila Parsotam
      Senior Director
      Pfizer, United Kingdom
    • Representative Invited
      Medical Director Global Access and Partnerships Program
      Janssen
    • Christophe Saillez
      Senior Manager
      GSK Biologicals, Belgium
    • Representative Invited
      Director, Emerging Markets, Global Regulatory Affairs
      GlaxoSmithKline
  • 3:30PM - 4:00PM

    NETWORKING COFFEE BREAK WITH EXHIBITORS
  • 4:00PM - 4:45PM

    Session 11: Plenary - Recap from break-out sessions
  • 4:45PM - 6:30PM

    Session 12: Closing - Challenges/barriers to access medicines


    Session Chair(s):

    • Corneille Traore
      Director
      West African Economic and Monetary Union (UEMOA) , Burkina Faso

    Speaker(s):

    • Merce Caturla
      Global Access Regulatory Lead (WHO/Africa/MEWA/EAP)
      Janssen Infectious Diseases, Belgium
    • Osaretin Jaiyeola
      Director, Regulatory Affairs - Sub-Saharan Africa
      GlaxoSmithKline, Ghana
    • Robert Lebeda
      Regulatory Affairs Manager
      Eli Lilly GmbH, Austria
    • Caroline Mendy
      IFPMA, Switzerland

Exhibits  

This conference gives the opportunity to a limited number of organisations to present themselves to the key stakeholders in the field through 6 sqm mini-booths.

Exhibitors are granted a unique opportunity to meet attendees before and after sessions and during all breaks. As there are only a very limited number of booths available, high visibility can be guaranteed. The mini-booths will be positioned to fit naturally into the flow of conference traffic, so the opportunities to engage with attendees are ensured.

ARC Exhibitor Application Form

For more details, please contact Roxann Schumacher, Exhibits Manger at roxann.schumacher@diaeurope.org or call +41 61 225 51 38.

Registration Fees 

Other Fees

Government/Nonprofit/Academia Overseas
€350.00
Industry Overseas
€1500.00
Government/Nonprofit/Academia Africa
€220.00
Industry Africa
€650.00
Register Online
« Back to Listing
DIA Recommends the Following Related Meetings & Training
Back To Top